AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
MEDICAL THERAPY OF ACTIVE CROHNS-DISEASE
Authors: JARNEROT G SANDBERGGERTZEN H TYSK C
Citation: G. Jarnerot et al., MEDICAL THERAPY OF ACTIVE CROHNS-DISEASE, Bailliere's clinical gastroenterology, 12(1), 1998, pp. 73-92
ESCHERICHIA-COLI AND PROTEUS-MIRABILIS INHIBIT THE PERINUCLEAR BUT NOT THE CIRCULATING ANTINEUTROPHIL CYTOPLASMIC ANTIBODY REACTION
Authors: YANG P DANIELSSON D JARNEROT G
Citation: P. Yang et al., ESCHERICHIA-COLI AND PROTEUS-MIRABILIS INHIBIT THE PERINUCLEAR BUT NOT THE CIRCULATING ANTINEUTROPHIL CYTOPLASMIC ANTIBODY REACTION, Scandinavian journal of gastroenterology, 33(5), 1998, pp. 529-534
ABSENCE OF LKM-1 ANTIBODY REACTIVITY IN AUTOIMMUNE AND HEPATITIS-C-RELATED CHRONIC LIVER-DISEASE IN SWEDEN
Authors: LINDGREN S BRAUN HB MICHEL G NEMETH A NILSSON S THOMEKROMER B ERIKSSON S BODEMAR G BROOME U DANIELSSON A HULTCRANTZ R JARNEROT G LOOF L OLSSON R PRYTZ H WALLERSTEDT S
Citation: S. Lindgren et al., ABSENCE OF LKM-1 ANTIBODY REACTIVITY IN AUTOIMMUNE AND HEPATITIS-C-RELATED CHRONIC LIVER-DISEASE IN SWEDEN, Scandinavian journal of gastroenterology, 32(2), 1997, pp. 175-178
CROHNS-DISEASE IS CAUSED BY LATER ENVIRONMENTAL-FACTORS
Authors: JARNEROT G
Citation: G. Jarnerot, CROHNS-DISEASE IS CAUSED BY LATER ENVIRONMENTAL-FACTORS, Gut, 41, 1997, pp. 37-37
INFLAMMATORY MEDIATORS IN COLLAGENOUS COLITIS
Authors: BOHR J TYSK C DANIELSSON D JARNEROT G BUKHAVE K RASKMADSEN J
Citation: J. Bohr et al., INFLAMMATORY MEDIATORS IN COLLAGENOUS COLITIS, Gut, 41, 1997, pp. 116-116
CYTOTOXIN PRODUCTION AND NEUTROPHIL ACTIVATION BY STRAINS OF HELICOBACTER-PYLORI ISOLATED FROM PATIENTS WITH PEPTIC-ULCERATION AND CHRONIC GASTRITIS
Authors: RAUTELIN H BLOMBERG B FREDLUND H JARNEROT G DANIELSSON D
Citation: H. Rautelin et al., CYTOTOXIN PRODUCTION AND NEUTROPHIL ACTIVATION BY STRAINS OF HELICOBACTER-PYLORI ISOLATED FROM PATIENTS WITH PEPTIC-ULCERATION AND CHRONIC GASTRITIS, Gut, 40(3), 1997, pp. 431-431
INCREASED NITRIC-OXIDE PRODUCTION IN COLLAGENOUS AND LYMPHOCYTIC COLITIS
Authors: LUNDBERG JON HERULF M OLESEN M BOHR J TYSK C WIKLUND NP MORCOS E HELLSTROM PM WEITZBERG E JARNEROT G
Citation: Jon. Lundberg et al., INCREASED NITRIC-OXIDE PRODUCTION IN COLLAGENOUS AND LYMPHOCYTIC COLITIS, European journal of clinical investigation, 27(10), 1997, pp. 869-871
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN INFLAMMATORY BOWEL-DISEASE AND COLLAGENOUS COLITIS - NO ASSOCIATION WITH LACTOFERRIN, BETA-GLUCURONIDASE, MYELOPEROXIDASE, OR PROTEINASE-3
Authors: YANG P BOHR J TYSK C DANIELSSON D JARNEROT G
Citation: P. Yang et al., ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN INFLAMMATORY BOWEL-DISEASE AND COLLAGENOUS COLITIS - NO ASSOCIATION WITH LACTOFERRIN, BETA-GLUCURONIDASE, MYELOPEROXIDASE, OR PROTEINASE-3, Inflammatory bowel diseases, 2(3), 1996, pp. 173-177
FUTURE ASPECTS ON INFLAMMATORY BOWEL-DISEASE
Authors: JARNEROT G
Citation: G. Jarnerot, FUTURE ASPECTS ON INFLAMMATORY BOWEL-DISEASE, Scandinavian journal of gastroenterology, 31, 1996, pp. 87-90
COLLAGENOUS COLITIS - A RETROSPECTIVE STUDY OF CLINICAL PRESENTATION AND TREATMENT IN 163 PATIENTS
Authors: BOHR J TYSK C ERIKSSON S ABRAHAMSSON H JARNEROT G
Citation: J. Bohr et al., COLLAGENOUS COLITIS - A RETROSPECTIVE STUDY OF CLINICAL PRESENTATION AND TREATMENT IN 163 PATIENTS, Gut, 39(6), 1996, pp. 846-851
AUTOANTIBODIES AND IMMUNOGLOBULINS IN COLLAGENOUS COLITIS
Authors: BOHR J TYSK C YANG P DANIELSSON D JARNEROT G
Citation: J. Bohr et al., AUTOANTIBODIES AND IMMUNOGLOBULINS IN COLLAGENOUS COLITIS, Gut, 39(1), 1996, pp. 73-76
FECAL STREAM DIVERSION IN PATIENTS WITH COLLAGENOUS COLITIS
Authors: JARNEROT G BOHR J TYSK C ERIKSSON S
Citation: G. Jarnerot et al., FECAL STREAM DIVERSION IN PATIENTS WITH COLLAGENOUS COLITIS, Gut, 38(1), 1996, pp. 154-154
WITHDRAWAL RATES BECAUSE OF DIARRHEA IN DIPENTUM-TREATED PATIENTS WITH ULCERATIVE-COLITIS ARE LOW WHEN DIPENTUM IS TAKEN WITH FOOD AND DOSETITRATED
Authors: JARNEROT G
Citation: G. Jarnerot, WITHDRAWAL RATES BECAUSE OF DIARRHEA IN DIPENTUM-TREATED PATIENTS WITH ULCERATIVE-COLITIS ARE LOW WHEN DIPENTUM IS TAKEN WITH FOOD AND DOSETITRATED, Gastroenterology, 110(4), 1996, pp. 932-932
INTESTINAL PERMEABILITY TO POLYETHYLENE GLYCOLS IN MONOZYGOTIC TWINS WITH CROHNS-DISEASE
Authors: LINDBERG E SODERHOLM JD OLAISON G TYSK C JARNEROT G
Citation: E. Lindberg et al., INTESTINAL PERMEABILITY TO POLYETHYLENE GLYCOLS IN MONOZYGOTIC TWINS WITH CROHNS-DISEASE, Scandinavian journal of gastroenterology, 30(8), 1995, pp. 780-783
SAMPLING VARIABILITY OF PERCUTANEOUS LIVER-BIOPSY IN PRIMARY SCLEROSING CHOLANGITIS
Authors: OLSSON R HAGERSTRAND I BROOME U DANIELSSON A JARNEROT G LOOF L PRYTZ H RYDEN BO WALLERSTEDT S
Citation: R. Olsson et al., SAMPLING VARIABILITY OF PERCUTANEOUS LIVER-BIOPSY IN PRIMARY SCLEROSING CHOLANGITIS, Journal of Clinical Pathology, 48(10), 1995, pp. 933-935
COLLAGENOUS COLITIS IN OREBRO, SWEDEN, AN EPIDEMIOLOGIC-STUDY 1984-1993
Authors: BOHR J TYSK C ERIKSSON S JARNEROT G
Citation: J. Bohr et al., COLLAGENOUS COLITIS IN OREBRO, SWEDEN, AN EPIDEMIOLOGIC-STUDY 1984-1993, Gut, 37(3), 1995, pp. 394-397
P-ANCA IN MONOZYGOTIC TWINS WITH INFLAMMATORY BOWEL-DISEASE
Authors: YANG P JARNEROT G DANIELSSON D TYSK C LINDBERG E
Citation: P. Yang et al., P-ANCA IN MONOZYGOTIC TWINS WITH INFLAMMATORY BOWEL-DISEASE, Gut, 36(6), 1995, pp. 887-890
AN ALTERNATIVE VIEW OF 5-ASA FORMULATIONS - REPLY
Authors: JARNEROT G
Citation: G. Jarnerot, AN ALTERNATIVE VIEW OF 5-ASA FORMULATIONS - REPLY, Gut, 36(4), 1995, pp. 639-640
NEW SALICYLATES AS MAINTENANCE TREATMENT IN ULCERATIVE-COLITIS - REPLY
Authors: JARNEROT G
Citation: G. Jarnerot, NEW SALICYLATES AS MAINTENANCE TREATMENT IN ULCERATIVE-COLITIS - REPLY, Gut, 36(4), 1995, pp. 640-640
COLLAGENOUS COLITIS AND FECAL STREAM DIVERSION
Authors: JARNEROT G TYSK C BOHR J ERIKSSON S
Citation: G. Jarnerot et al., COLLAGENOUS COLITIS AND FECAL STREAM DIVERSION, Gastroenterology, 109(2), 1995, pp. 449-455
COLCHICINE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS
Authors: OLSSON R BROOME U DANIELSSON A HAGERSTRAND I JARNEROT G LOOF L PRYTZ H RYDEN BO WALLERSTEDT S
Citation: R. Olsson et al., COLCHICINE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS, Gastroenterology, 108(4), 1995, pp. 1199-1203
NONOPSONIC ACTIVATION OF NEUTROPHILS AND CYTOTOXIN PRODUCTION BY HELICOBACTER-PYLORI - ULCEROGENIC MARKERS
Authors: RAUTELIN H BLOMBERG B JARNEROT G DANIELSSON D
Citation: H. Rautelin et al., NONOPSONIC ACTIVATION OF NEUTROPHILS AND CYTOTOXIN PRODUCTION BY HELICOBACTER-PYLORI - ULCEROGENIC MARKERS, Scandinavian journal of gastroenterology, 29(2), 1994, pp. 128-132
NEW SALICYLATES AS MAINTENANCE TREATMENT IN ULCERATIVE-COLITIS
Authors: JARNEROT G
Citation: G. Jarnerot, NEW SALICYLATES AS MAINTENANCE TREATMENT IN ULCERATIVE-COLITIS, Gut, 35(9), 1994, pp. 1155-1158
OPTIMUM DOSE OF OLSALAZINE FOR MAINTAINING REMISSION IN ULCERATIVE-COLITIS
Authors: TRAVIS SPL TYSK C DESILVA HJ SANDBERGGERTZEN H JEWELL DP JARNEROT G
Citation: Spl. Travis et al., OPTIMUM DOSE OF OLSALAZINE FOR MAINTAINING REMISSION IN ULCERATIVE-COLITIS, Gut, 35(9), 1994, pp. 1282-1286
PLATELET DENSITY, SIZE AND RELEASE REACTION IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE
Authors: SANDBERGGERTZEN H JAREMO P JARNEROT G
Citation: H. Sandberggertzen et al., PLATELET DENSITY, SIZE AND RELEASE REACTION IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE, Gastroenterology, 106(4), 1994, pp. 10000766-10000766
Risultati: 1-25 | 26-28